TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) Investor Securities Class Action Lawsuit 11/18/2021

  • If you purchased a significant amount of shares of Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) between May 11, 2021 and October 5, 2021, and / or if you purchased any NYSE: DNA shares prior to May 2021 and continue to hold any of those shares, you have certain options and for certain investors are short and strict deadlines running. Deadline: January 17, 2022. NYSE: DNA investors should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Lawsuit Overview

July 18, 2022 - A  second amended complaint was filed. May 26, 2022 - An amended complaint was filed. November 18, 2021 - An investor in shares of Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) filed a lawsuit in the U.S. District Court for the Northern District of California over alleged violations of Federal Securities Laws by Ginkgo Bioworks Holdings, Inc. f/k/a Soaring Eagle Acquisiti...



You must register (for free) or login to view the entire case.

Click here to Sign In or Register (for a free account)